Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSafaa Ali
About this trial
aim of the work
1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia. 2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.
Eligibility criteria
Qualifiers
Patients with acute lymphocytic leukemia or chronic lymphocytic leukemia of both genders at any age.
Disqualifiers
Patients with any other type of malignancies
Trial design
Treatments tested in this trial
- Not listed
Trial groups
84 Participants
are grouped into 3 trial groupsLocations
Sponsors and collaborators
Safaa Ali
Lead sponsor
Assiut University
Sponsor institution
Source ClinicalTrials.gov